• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    AI Drug Discovery Market Size

    ID: MRFR/Pharma/7918-CR
    200 Pages
    Rahul Gotadki
    July 2023

    Artificial Intelligence in Drug Discovery Market Research Report By Application (Target Identification, Lead Optimization, Drug Repurposing, Clinical Trials, Preclinical Testing), By Technology (Machine Learning, Natural Language Processing, Deep Learning, Knowledge Graphs, Robotic Process Automation), By End Use (Pharmaceutical Companies, Biotechnology Firms, Research Institutions, Academic In...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    AI Drug Discovery Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Ai Drug Discovery Size

    AI Drug Discovery Market Growth Projections and Opportunities

    The market for AI-powered solutions in drug discovery is experiencing robust growth, propelled by several key factors. One of the primary drivers is the escalating adoption of artificial intelligence (AI) in drug discovery endeavors. This trend is indicative of a paradigm shift within the pharmaceutical and biotechnology industries, where AI technologies are increasingly recognized for their potential to enhance and expedite the drug discovery and development processes. In addition to the surge in AI adoption, the market is benefiting from a notable uptick in strategic initiatives focused on integrating AI into drug discovery workflows. Pharmaceutical companies and research institutions are actively embracing AI technologies as integral components of their strategies, acknowledging the transformative impact these tools can have on efficiency and outcomes in drug development. The concerted efforts in this regard contribute significantly to the overall market expansion. A noteworthy contributor to the burgeoning landscape is the proliferation of AI-powered drug discovery start-ups. The entrepreneurial ecosystem is witnessing a surge in the establishment of companies dedicated to leveraging AI for drug discovery purposes. These start-ups bring innovation, agility, and specialized expertise to the field, fostering a competitive and dynamic environment that accelerates advancements in AI applications for drug development. Moreover, the market is experiencing a positive influence from the escalating number of public-private partnerships. Collaborations between governmental entities, research institutions, and private enterprises are becoming increasingly prevalent, fostering a collaborative approach towards integrating AI into drug discovery and development. These partnerships not only facilitate the sharing of resources and knowledge but also contribute to the development of comprehensive and robust AI solutions that can address the complexities of the drug discovery process. Another crucial factor driving the market growth is the rising demand for novel drug therapies. As the healthcare landscape evolves, there is a growing need for innovative and effective treatment solutions.  Additionally, the life science industry's expanding manufacturing capacities further fuel the demand for AI-enabled solutions in drug discovery. The increasing scale of pharmaceutical production necessitates advanced and efficient approaches to drug development, and AI emerges as a transformative tool in this context. By streamlining processes, optimizing resource utilization, and expediting decision-making, AI contributes to enhancing the overall efficiency of drug discovery in the backdrop of expanding manufacturing capabilities. In conclusion, the market for AI-powered solutions in drug discovery is witnessing a significant growth trajectory, propelled by a confluence of factors. The increasing adoption of AI, strategic initiatives, the emergence of AI-powered start-ups, and the prevalence of public-private partnerships collectively contribute to the market's expansion. Furthermore, the growing demand for innovative drug therapies and the expanding manufacturing capacities in the life science industry underscore the pivotal role that AI-enabled solutions play in shaping the future of drug discovery and development processes. As these trends continue to evolve, the synergy between artificial intelligence and drug discovery is poised to usher in a new era of efficiency and innovation in the pharmaceutical and biotechnology sectors.

    AI Drug Discovery Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the Artificial Intelligence in Drug Discovery Market was valued at 0.93 USD Billion in 2024 and is projected to reach 11.82 USD Billion by 2035, reflecting a CAGR of 26.00% from 2025 to 2035. The market is driven by the need for efficient drug development processes, increased investment in biotechnology, and advancements in personalized medicine.

    Key Market Trends & Highlights

    The Global Artificial Intelligence in Drug Discovery Market is witnessing transformative growth due to several key trends.

    • Target Identification is expected to grow from 1.1 USD Billion in 2024 to 6.3 USD Billion by 2035. Lead Optimization will increase from 1.0 USD Billion in 2024 to 5.5 USD Billion by 2035. Drug Repurposing is anticipated to reach 4.5 USD Billion by 2035, highlighting its growing relevance. North America is projected to dominate the market, growing from 2.0 USD Billion in 2024 to 12.0 USD Billion by 2035.

    Market Size & Forecast

    2024 Market Size USD 0.93 Billion
    2035 Market Size USD 11.82 Billion
    CAGR (2025-2035) 26.00%
    Largest Regional Market Share in 2024 North America.

    Major Players

    <p>Key players include IBM, NuMedii, Atomwise, Exscientia, Recursion Pharmaceuticals, Strateos, Insilico Medicine, Google DeepMind, Zebra Medical Vision, Biorelate, Microsoft, BenevolentAI, and CureMetrix.</p>

    Market Trends

    The Artificial Intelligence in Drug Discovery Market is witnessing substantial growth, propelled by several critical market drivers. A key factor is the growing demand for expedited drug development processes, which conventional methods frequently find challenging to accomplish. Artificial intelligence technology provides advanced solutions for predictive analytics, improving the efficiency of drug discovery. Furthermore, the increasing incidence of chronic diseases and the growing need for personalized medicine are driving the adoption of AI to enhance drug compounds and pinpoint promising candidates.

    Regulatory bodies worldwide, recognizing the potential of AI in reducing time and costs in drug development, are also beginning to establish frameworks that support its integration into research processes. There are many opportunities to be explored within this market, particularly in emerging economies where healthcare needs are expanding rapidly. Companies can leverage AI to address specific local health challenges and invest in partnerships with academic institutions for innovative research collaborations. Moreover, the increasing availability of open-access biomedical data sets presents a unique opportunity for AI systems to improve their learning and accuracy in drug discovery. 

    Recent trends show that pharmaceutical companies are increasingly adopting machine learning algorithms and natural language processing in their research pipelines. This shift is enhancing target identification and optimizing clinical trial designs, leading to better outcomes in drug performance. Collaborative initiatives between AI technology firms and pharmaceutical companies are increasingly prevalent, indicating a trend toward synergistic growth. Interest in AI for drug discovery is anticipated to grow, driven by technological advancements that facilitate transformative changes in the global processes of drug discovery and development.

     

    <p>The integration of artificial intelligence in drug discovery is poised to revolutionize the pharmaceutical landscape, enhancing the efficiency of drug development processes and potentially leading to more effective therapies.</p>

    U.S. National Institutes of Health (NIH)

    AI Drug Discovery Market Market Drivers

    Market Growth Projections

    The Global Artificial Intelligence (AI) in Drug Discovery Market Industry is characterized by robust growth projections. The market is expected to reach 4.4 USD Billion in 2024 and is anticipated to expand to 25 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 17.11% from 2025 to 2035. Such projections indicate a strong demand for AI technologies that enhance drug discovery processes, driven by the need for more efficient and effective therapeutic solutions. The increasing adoption of AI across various stages of drug development is likely to reshape the pharmaceutical landscape, making it a focal point for future investments.

    Growing Investment in Biotechnology

    The Global Artificial Intelligence (AI) in Drug Discovery Market Industry is witnessing a surge in investment within the biotechnology sector. Investors are increasingly recognizing the potential of AI to revolutionize drug discovery and development. This influx of capital is facilitating the development of innovative AI-driven platforms that enhance the efficiency and accuracy of drug discovery processes. As a result, the market is anticipated to grow significantly, with projections indicating a rise to 25 USD Billion by 2035. The convergence of biotechnology and AI is fostering an environment ripe for breakthroughs in therapeutic solutions, thereby attracting both public and private funding.

    Regulatory Support for AI Integration

    The Global Artificial Intelligence (AI) in Drug Discovery Market Industry benefits from increasing regulatory support for the integration of AI technologies in drug development. Regulatory bodies are beginning to recognize the potential of AI to enhance the safety and efficacy of new drugs. This support is crucial as it encourages pharmaceutical companies to adopt AI-driven approaches in their research and development processes. The positive regulatory environment is likely to contribute to the market's growth, with expectations of reaching 4.4 USD Billion in 2024. By fostering innovation while ensuring compliance, regulatory frameworks are paving the way for the broader acceptance of AI in drug discovery.

    Rising Demand for Personalized Medicine

    The Global Artificial Intelligence (AI) in Drug Discovery Market Industry is experiencing a notable surge in demand for personalized medicine. This trend is driven by the increasing recognition that individualized treatment plans can enhance patient outcomes. AI technologies facilitate the analysis of vast datasets, including genetic information, to identify potential drug candidates tailored to specific patient profiles. As a result, the market is projected to reach 4.4 USD Billion in 2024, reflecting a growing investment in AI-driven solutions that optimize drug development processes. The ability to customize therapies not only improves efficacy but also reduces adverse effects, thereby attracting significant interest from pharmaceutical companies.

    Efficiency in Drug Development Processes

    The Global Artificial Intelligence (AI) in Drug Discovery Market Industry is significantly influenced by the efficiency that AI brings to drug development processes. Traditional drug discovery methods are often time-consuming and costly, with a high failure rate. AI algorithms can analyze complex biological data, predict molecular interactions, and identify viable drug candidates more rapidly than conventional methods. This efficiency is crucial as the market is expected to expand to 25 USD Billion by 2035, driven by the need for faster and more cost-effective drug development. By streamlining workflows and reducing time-to-market, AI technologies are becoming indispensable in the pharmaceutical landscape.

    Advancements in Machine Learning Algorithms

    The Global Artificial Intelligence (AI) in Drug Discovery Market Industry is propelled by advancements in machine learning algorithms. These algorithms enable researchers to process and interpret large volumes of data, leading to more accurate predictions of drug efficacy and safety. For instance, deep learning techniques are being employed to analyze chemical structures and biological data, which enhances the identification of potential drug candidates. As the market continues to evolve, the compound annual growth rate (CAGR) is projected at 17.11% from 2025 to 2035. This growth underscores the increasing reliance on sophisticated AI models to drive innovation in drug discovery.

    Market Segment Insights

    Artificial Intelligence in Drug Discovery Market Application Insights

    <p>The Artificial Intelligence in Drug Discovery Market is witnessing substantial growth, with specific emphasis on the Application segment that encompasses various critical areas such as target identification, lead optimization, drug repurposing, clinical trials, and preclinical testing. Target identification holds a noteworthy position with market values of 0.815 USD billion in 2024 and 4.612 USD billion in 2035, emphasizing its significance in the early stages of drug discovery where pinpointing the right biological targets is crucial for successful outcomes.</p>

    <p>Lead optimization closely follows with a valuation of 0.896 USD billion in 2024, further projected to reach 5.016 USD billion in 2035; this segment is essential as it enhances existing drug candidates, ensuring improved efficacy and reduced side effects before proceeding to clinical trials. Drug repurposing showcases a market value of 0.978 USD billion in 2024, escalating to 5.744 USD billion by 2035, marking a strategic approach where existing drugs are evaluated for new therapeutic uses, thus reducing time and costs typically associated with traditional drug development.</p>

    <p>Clinical trials application, valued at 1.467 USD billion in 2024 and expected to attain 8.091 USD billion in 2035, plays a vital role in evaluating drug safety and efficacy, with AI technologies facilitating better patient selection and trial design, which is fundamental in the increasingly complex clinical environments. Preclinical testing appears to have a smaller valuation, recorded at 0.244 USD billion in 2024, expected to grow to 1.537 USD billion by 2035, underscoring the necessity of exhaustive testing before human trials to ensure drug safety and viability.</p>

    AI in Drug Discovery Market Technology Insights

    <p>The Artificial Intelligence in Drug Discovery Market by technology, encompasses key categories such as machine learning, natural language processing deep learning, knowledge graphs, and robotic process automation. Machine learning plays a pivotal role by analyzing vast datasets to identify potential drug candidates, thus enhancing efficiency and accuracy in drug development processes. Natural language processing is essential for extracting valuable insights from scientific literature, facilitating quicker research advancements.</p>

    <p>Deep learning significantly contributes to predictive modeling, allowing for better-targeted therapies. Knowledge Graphs streamline data relationships by visualizing connections across diverse datasets, thereby improving decision-making efficiencies in drug discovery. Lastly, robotic process automation optimizes repetitive tasks, allowing researchers to focus on innovation.</p>

    Artificial Intelligence in Drug Discovery Market End Use Insights

    <p>The global artificial intelligence in drug discovery by end use encompasses pharmaceutical companies, biotechnology firms, research institutions, and academic institutions. Pharmaceutical companies leverage artificial intelligence to enhance the efficiency and accuracy of drug development processes, leading to shortened timelines and reduced costs in bringing new therapies to market. Biotechnology firms also play a crucial role, using AI to streamline the discovery of novel drug candidates and to optimize clinical trials, thereby significantly improving success rates.</p>

    <p>Research institutions utilize AI to enhance their investigative capabilities in drug discovery, creating vast opportunities for innovation and breakthroughs. Academic institutions increasingly integrate AI into their educational curricula, equipping the next generation of scientists with essential skills for future advancements in the industry.</p>

    <p>The increasing demand for personalized medicine and the necessity for accelerated drug development are driving the expansion of the global artificial intelligence market in drug discovery. Technological advancements and rising investments in research and development significantly contribute to market growth, highlighting the critical role of each end-use segment in promoting a collaborative approach to transforming drug discovery practices.</p>

    Artificial Intelligence in Drug Discovery Market Workflow Insights

    <p>The Artificial Intelligence in Drug Discovery Market by workflow encompasses various components, including data mining, predictive modeling, clinical data management, and assay development. Data mining is essential for extracting valuable insights from vast datasets, assisting researchers in identifying potential drug candidates.</p>

    <p>Predictive modeling aids in forecasting outcomes based on historical data, which is crucial for informed decision-making in drug development. Clinical data management ensures the integrity and accessibility of clinical trial data, facilitating smoother trials and regulatory approvals. Assay development remains significant as it directly influences the effectiveness and accuracy of identifying therapeutic compounds.</p>

    Get more detailed insights about Artificial Intelligence (AI) in Drug Discovery Market Research Report - Forecast to 2035

    Regional Insights

    North America led the way with a valuation of 1.76 USD billion in 2024. It is projected to reach 10.11 USD billion by 2035, showcasing its majority holding in market dynamics driven by advanced research and technology initiatives. Europe follows with a valuation of 1.1 USD billion in 2024, expected to grow to 6.3 USD billion, reflecting a strong focus on pharmaceutical innovation and regulatory support.

    Asia Pacific, valued at 0.92 USD billion in 2024, is anticipated to reach 5.32 USD billion, making it a growing hub for investment in AI technologies amidst rising healthcare demands. South America and the Middle East and Africa present smaller market shares, valued at 0.22 USD billion and 0.24 USD billion, respectively, but are expected to expand to 1.3 USD billion and 1.87 USD billion by 2035. Despite their smaller figures, these regions are leveraging local partnerships and investment incentives to foster growth in the AI-driven drug discovery landscape.

    Artificial Intelligence in Drug Discovery Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The global market for artificial intelligence in drug development has emerged as a crucial priority for prominent pharmaceutical and technology businesses aiming to optimize their drug discovery processes and reduce time to market. This sector leverages advanced machine learning algorithms and data analytics, significantly improving the efficiency of identifying potential drug candidates. As the demand for customized medicine and new medicines escalates, competition in this sector intensifies, emphasizing strategic collaborations, technological improvements, and the development of intellectual property.Companies are currently exploring the integration of AI for medication identification, as well as for the optimization of clinical trials and post-market surveillance.

    The environment features significant investments in research and development, focused on developing advanced AI platforms that can predict medication interactions and side effects, with the goal of optimizing each phase of the drug development process.

    Novartis stands out in the Artificial Intelligence in Drug Discovery Market due to its commitment to innovation and technological adoption. With a robust research and development pipeline, Novartis has integrated AI into various aspects of its drug discovery activities, allowing for more efficient screening and optimizing molecular drug design. It’s strategic collaborations with tech firms and academic institutions fortify its market presence, enabling Novartis to leverage state-of-the-art AI solutions.

    Novartis's strengths lie in its extensive portfolio covering a diverse range of therapeutic areas and its capability to utilize AI in repurposing existing drugs, potentially speeding up the drug discovery process. This forward-thinking approach combined with Novartis's established industry reputation solidifies its competitive edge in leveraging AI technologies within drug discovery for global applications.

    Atomwise is another key player in the Artificial Intelligence in Drug Discovery Market, recognized for its innovative use of AI in drug design and development. The company’s proprietary technology utilizes deep learning algorithms to predict the effectiveness of potential drug molecules, substantially accelerating the initial phases of drug discovery. Atomwise has made significant strides in creating strategic partnerships with various pharmaceutical companies and research institutions globally, allowing for extensive application of its technology in diverse therapeutic areas.

    The company's strength lies in its unique AI platform, which offers efficient virtual screening services, yielding a high success rate in drug candidates' identification. Atomwise has also engaged in notable collaborations and mergers that have bolstered its market presence, enhancing its product offerings and capabilities in drug discovery. This focus on AI and strategic expansion allows Atomwise to maintain a competitive position in the rapidly evolving landscape of drug discovery, driving innovation and efficiency on a global scale.

    Key Companies in the AI Drug Discovery Market market include

    Industry Developments

    The global market for artificial intelligence in drug discovery is experiencing significant growth, as leading pharmaceutical firms such as Novartis, Pfizer, and AstraZeneca utilize AI to enhance the efficiency of drug development. Atomwise continues to be a prominent entity, recognized for its AtomNet® platform that facilitates the virtual screening of billions of compounds, greatly enhancing the process of early-stage drug identification. Other firms like Insilico Medicine and DeepMind (through Isomorphic Labs) have secured significant funding, highlighting the industry's innovative capabilities and growing investor trust.

    Exscientia’s collaboration with Bristol Myers Squibb, announced in May 2021, represented a significant milestone in their partnerships. The agreement, worth more than $1.2 billion, focuses on leveraging AI to enhance the efficiency of drug development across various therapeutic targets. The collaboration has successfully produced a first-in-human trial for a PKC-theta inhibitor (EXS4318), highlighting the tangible benefits of AI-driven innovation in clinical development.

    Despite the prevailing market optimism, it is crucial to clarify that IBM did not acquire any AI drug discovery firm in August 2023, contrary to certain reports. In 2022, the organization restructured its earlier healthcare AI initiatives, leading to the formation of Merative. Overall, the advancements in AI within the drug discovery sector are set for ongoing growth, fueled by strategic partnerships, evolving platforms, and a significant focus on technology integration.

    Future Outlook

    AI Drug Discovery Market Future Outlook

    <p>The Artificial Intelligence in Drug Discovery Market is projected to grow at a 26.00% CAGR from 2025 to 2035, driven by technological advancements, increased R&amp;D investments, and demand for personalized medicine.</p>

    New opportunities lie in:

    • <p>Develop AI-driven platforms for predictive analytics in drug efficacy. Invest in partnerships with biotech firms for collaborative AI research. Leverage machine learning to enhance drug repurposing strategies.</p>

    <p>By 2035, the market is expected to reach unprecedented levels, reflecting robust growth and innovation.</p>

    Market Segmentation

    Artificial Intelligence in Drug Discovery Market End Use Outlook

    • Pharmaceutical Companies
    • Biotechnology Firms
    • Research Institutions
    • Academic Institution 

    Artificial Intelligence in Drug Discovery Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Artificial Intelligence in Drug Discovery Market Workflow Outlook

    • Data Mining
    • Predictive Modeling
    • Clinical Data Management
    • Assay Development

    Artificial Intelligence in Drug Discovery Market Technology Outlook

    • Machine Learning
    • Natural Language Processing
    • Deep Learning
    • Knowledge Graphs
    • Robotic Process Automation

    Artificial Intelligence in Drug Discovery Market Application Outlook

    • Target Identification
    • Lead Optimization
    • Drug Repurposing
    • Clinical Trials
    • Preclinical Testing

    Report Scope

    Report Attribute/MetricDetails
    Market Size 20244.4 (USD Billion)
    Market Size 203511.82 (USD Billion)
    Compound Annual Growth Rate (CAGR)26.00% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2023
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledIBM, NuMedii, Atomwise, Exscientia, Recursion Pharmaceuticals, Strateos, Insilico Medicine, Google, DeepMind, Zebra Medical Vision, Biorelate, Microsoft, BenevolentAI, CureMetrix, Cloud Pharmaceuticals
    Segments CoveredApplication, Technology, End Use, Workflow, Regional
    Key Market OpportunitiesEnhanced drug candidate identification, Accelerated clinical trial processes, Cost reduction in drug development, Improved patient stratification, Data-driven personalized medicine solutions
    Key Market DynamicsData availability, Increased R investment, Technological advancements, Regulatory compliance pressures, Collaborations and partnerships
    Countries CoveredNorth America, Europe, APAC, South America, MEA
    Market Size 20251.17 (USD Billion)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What was the value of the Artificial Intelligence in Drug Discovery Market in 2024?

    The global artificial intelligence in drug discovery was valued at 4.4 USD billion in 2024.

    What is the expected value of the Artificial Intelligence in Drug Discovery Market by 2035?

    By 2035, the Artificial Intelligence in Drug Discovery Market is expected to reach a valuation of 25.0 USD billion.

    What is the expected CAGR for the Artificial Intelligence in Drug Discovery Market from 2025 to 2035?

    The expected CAGR for the Artificial Intelligence in Drug Discovery Market from 2025 to 2035 is 17.11%.

    Which region dominated the Artificial Intelligence in Drug Discovery Market in 2024?

    North America dominated the Artificial Intelligence in Drug Discovery Market in 2024 with a valuation of 1.76 USD billion.

    What is the forecast for the Artificial Intelligence in Drug Discovery Market in North America by 2035?

    By 2035, the North America artificial intelligence in drug discovery market is expected to total 10.11 USD billion.

    What are the key applications of Artificial Intelligence in Drug Discovery?

    Key applications include target identification, lead optimization, drug repurposing, clinical trials, and preclinical testing.

    Which application is projected to contribute the most to the revenue share in 2035?

    The clinical trials application segment is projected to contribute the most to the market size, expected to reach 8.091 USD billion in 2035.

    Who are the major players in the Artificial Intelligence in Drug Discovery Market?

    Major players include Novartis, Atomwise, Recursion Pharmaceuticals, Pfizer, Microsoft, and others.

    What is the anticipated market size for Drug Repurposing Application by 2035?

    The drug repurposing application segment is anticipated to total 5.744 USD billion by 2035.

    How much value did the Asia Pacific Artificial Intelligence in Drug Discovery generate in 2024, and what is its projection for 2035?

    The Asia Pacific market was valued at 0.92 USD billion in 2024 and is projected to grow to 5.32 USD billion by 2035.

    1. AI in Drug Discovery Market Segmentation AI in Drug Discovery Market By Application (USD Billion, 2019-2035) Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical Testing AI in Drug Discovery Market By Technology (USD Billion, 2019-2035) Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process Automation AI in Drug Discovery Market By End Use (USD Billion, 2019-2035) Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic Institutions AI in Drug Discovery Market By Workflow (USD Billion, 2019-2035) Data MiningPredictive ModelingClinical Data ManagementAssay Development AI in Drug Discovery Market By Regional (USD Billion, 2019-2035) North AmericaEuropeSouth AmericaAsia PacificMiddle East and Africa AI in Drug Discovery Market Regional Outlook (USD Billion, 2019-2035) North America Outlook (USD Billion, 2019-2035) North America AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingNorth America AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationNorth America AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsNorth America AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentNorth America AI in Drug Discovery Market by Regional Type USCanadaUS Outlook (USD Billion, 2019-2035)US AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingUS AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationUS AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsUS AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentCANADA Outlook (USD Billion, 2019-2035)CANADA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingCANADA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationCANADA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsCANADA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentEurope Outlook (USD Billion, 2019-2035) Europe AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingEurope AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationEurope AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsEurope AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentEurope AI in Drug Discovery Market by Regional Type GermanyUKFranceRussiaItalySpainRest of EuropeGERMANY Outlook (USD Billion, 2019-2035)GERMANY AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingGERMANY AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationGERMANY AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsGERMANY AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentUK Outlook (USD Billion, 2019-2035)UK AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingUK AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationUK AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsUK AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentFRANCE Outlook (USD Billion, 2019-2035)FRANCE AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingFRANCE AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationFRANCE AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsFRANCE AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentRUSSIA Outlook (USD Billion, 2019-2035)RUSSIA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingRUSSIA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationRUSSIA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsRUSSIA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentITALY Outlook (USD Billion, 2019-2035)ITALY AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingITALY AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationITALY AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsITALY AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentSPAIN Outlook (USD Billion, 2019-2035)SPAIN AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingSPAIN AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationSPAIN AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsSPAIN AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentREST OF EUROPE Outlook (USD Billion, 2019-2035)REST OF EUROPE AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingREST OF EUROPE AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationREST OF EUROPE AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsREST OF EUROPE AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentAPAC Outlook (USD Billion, 2019-2035) APAC AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingAPAC AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationAPAC AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsAPAC AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentAPAC AI in Drug Discovery Market by Regional Type ChinaIndiaJapanSouth KoreaMalaysiaThailandIndonesiaRest of APACCHINA Outlook (USD Billion, 2019-2035)CHINA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingCHINA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationCHINA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsCHINA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentINDIA Outlook (USD Billion, 2019-2035)INDIA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingINDIA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationINDIA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsINDIA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentJAPAN Outlook (USD Billion, 2019-2035)JAPAN AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingJAPAN AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationJAPAN AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsJAPAN AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentSOUTH KOREA Outlook (USD Billion, 2019-2035)SOUTH KOREA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingSOUTH KOREA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationSOUTH KOREA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsSOUTH KOREA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentMALAYSIA Outlook (USD Billion, 2019-2035)MALAYSIA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingMALAYSIA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationMALAYSIA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsMALAYSIA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentTHAILAND Outlook (USD Billion, 2019-2035)THAILAND AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingTHAILAND AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationTHAILAND AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsTHAILAND AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentINDONESIA Outlook (USD Billion, 2019-2035)INDONESIA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingINDONESIA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationINDONESIA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsINDONESIA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentREST OF APAC Outlook (USD Billion, 2019-2035)REST OF APAC AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingREST OF APAC AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationREST OF APAC AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsREST OF APAC AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentSouth America Outlook (USD Billion, 2019-2035) South America AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingSouth America AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationSouth America AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsSouth America AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentSouth America AI in Drug Discovery Market by Regional Type BrazilMexicoArgentinaRest of South AmericaBRAZIL Outlook (USD Billion, 2019-2035)BRAZIL AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingBRAZIL AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationBRAZIL AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsBRAZIL AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentMEXICO Outlook (USD Billion, 2019-2035)MEXICO AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingMEXICO AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationMEXICO AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsMEXICO AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentARGENTINA Outlook (USD Billion, 2019-2035)ARGENTINA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingARGENTINA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationARGENTINA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsARGENTINA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentREST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)REST OF SOUTH AMERICA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingREST OF SOUTH AMERICA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationREST OF SOUTH AMERICA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsREST OF SOUTH AMERICA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentMEA Outlook (USD Billion, 2019-2035) MEA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingMEA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationMEA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsMEA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentMEA AI in Drug Discovery Market by Regional Type GCC CountriesSouth AfricaRest of MEAGCC COUNTRIES Outlook (USD Billion, 2019-2035)GCC COUNTRIES AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingGCC COUNTRIES AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationGCC COUNTRIES AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsGCC COUNTRIES AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentSOUTH AFRICA Outlook (USD Billion, 2019-2035)SOUTH AFRICA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingSOUTH AFRICA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationSOUTH AFRICA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsSOUTH AFRICA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay DevelopmentREST OF MEA Outlook (USD Billion, 2019-2035)REST OF MEA AI in Drug Discovery Market by Application Type Target IdentificationLead OptimizationDrug RepurposingClinical TrialsPreclinical TestingREST OF MEA AI in Drug Discovery Market by Technology Type Machine LearningNatural Language ProcessingDeep LearningKnowledge GraphsRobotic Process AutomationREST OF MEA AI in Drug Discovery Market by End Use Type Pharmaceutical CompaniesBiotechnology FirmsResearch InstitutionsAcademic InstitutionsREST OF MEA AI in Drug Discovery Market by Workflow Type Data MiningPredictive ModelingClinical Data ManagementAssay Development  

    Artificial Intelligence in Drug Discovery Market Segmentation

    Artificial Intelligence in Drug Discovery Market By Technology (USD Billion, 2019-2032)

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    Artificial Intelligence in Drug Discovery Market By Application (USD Billion, 2019-2032)

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    Artificial Intelligence in Drug Discovery Market By End Use (USD Billion, 2019-2032)

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    Artificial Intelligence in Drug Discovery Market By Deployment Type (USD Billion, 2019-2032)

    Cloud-based

    On-premise

    Artificial Intelligence in Drug Discovery Market By Regional (USD Billion, 2019-2032)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Artificial Intelligence in Drug Discovery Market Regional Outlook (USD Billion, 2019-2032)

    North America Outlook (USD Billion, 2019-2032)

    North America Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    North America Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    North America Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    North America Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    North America Artificial Intelligence in Drug Discovery Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2032)

    US Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    US Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    US Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    US Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    CANADA Outlook (USD Billion, 2019-2032)

    CANADA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    CANADA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    CANADA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    CANADA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    Europe Outlook (USD Billion, 2019-2032)

    Europe Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    Europe Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    Europe Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    Europe Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    Europe Artificial Intelligence in Drug Discovery Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2032)

    GERMANY Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    GERMANY Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    GERMANY Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    GERMANY Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    UK Outlook (USD Billion, 2019-2032)

    UK Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    UK Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    UK Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    UK Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    FRANCE Outlook (USD Billion, 2019-2032)

    FRANCE Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    FRANCE Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    FRANCE Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    FRANCE Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    RUSSIA Outlook (USD Billion, 2019-2032)

    RUSSIA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    RUSSIA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    RUSSIA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    RUSSIA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    ITALY Outlook (USD Billion, 2019-2032)

    ITALY Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    ITALY Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    ITALY Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    ITALY Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    SPAIN Outlook (USD Billion, 2019-2032)

    SPAIN Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    SPAIN Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    SPAIN Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    SPAIN Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    REST OF EUROPE Outlook (USD Billion, 2019-2032)

    REST OF EUROPE Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    REST OF EUROPE Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    REST OF EUROPE Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    REST OF EUROPE Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    APAC Outlook (USD Billion, 2019-2032)

    APAC Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    APAC Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    APAC Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    APAC Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    APAC Artificial Intelligence in Drug Discovery Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2032)

    CHINA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    CHINA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    CHINA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    CHINA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    INDIA Outlook (USD Billion, 2019-2032)

    INDIA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    INDIA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    INDIA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    INDIA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    JAPAN Outlook (USD Billion, 2019-2032)

    JAPAN Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    JAPAN Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    JAPAN Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    JAPAN Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    SOUTH KOREA Outlook (USD Billion, 2019-2032)

    SOUTH KOREA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    SOUTH KOREA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    SOUTH KOREA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    SOUTH KOREA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    MALAYSIA Outlook (USD Billion, 2019-2032)

    MALAYSIA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    MALAYSIA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    MALAYSIA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    MALAYSIA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    THAILAND Outlook (USD Billion, 2019-2032)

    THAILAND Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    THAILAND Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    THAILAND Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    THAILAND Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    INDONESIA Outlook (USD Billion, 2019-2032)

    INDONESIA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    INDONESIA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    INDONESIA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    INDONESIA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    REST OF APAC Outlook (USD Billion, 2019-2032)

    REST OF APAC Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    REST OF APAC Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    REST OF APAC Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    REST OF APAC Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    South America Outlook (USD Billion, 2019-2032)

    South America Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    South America Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    South America Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    South America Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    South America Artificial Intelligence in Drug Discovery Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2032)

    BRAZIL Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    BRAZIL Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    BRAZIL Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    BRAZIL Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    MEXICO Outlook (USD Billion, 2019-2032)

    MEXICO Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    MEXICO Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    MEXICO Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    MEXICO Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    ARGENTINA Outlook (USD Billion, 2019-2032)

    ARGENTINA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    ARGENTINA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    ARGENTINA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    ARGENTINA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2032)

    REST OF SOUTH AMERICA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    REST OF SOUTH AMERICA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    REST OF SOUTH AMERICA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    REST OF SOUTH AMERICA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    MEA Outlook (USD Billion, 2019-2032)

    MEA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    MEA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    MEA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    MEA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    MEA Artificial Intelligence in Drug Discovery Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2032)

    GCC COUNTRIES Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    GCC COUNTRIES Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    GCC COUNTRIES Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    GCC COUNTRIES Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    SOUTH AFRICA Outlook (USD Billion, 2019-2032)

    SOUTH AFRICA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    SOUTH AFRICA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    SOUTH AFRICA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    SOUTH AFRICA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    REST OF MEA Outlook (USD Billion, 2019-2032)

    REST OF MEA Artificial Intelligence in Drug Discovery Market by Technology Type

    Machine Learning

    Natural Language Processing

    Expert Systems

    Deep Learning

    REST OF MEA Artificial Intelligence in Drug Discovery Market by Application Type

    Drug Repurposing

    Clinical Trial Patient Recruitment

    Drug Discovery

    Preclinical Research

    REST OF MEA Artificial Intelligence in Drug Discovery Market by End Use Type

    Pharmaceutical Companies

    Biotechnology Companies

    Research Institutions

    Contract Research Organizations

    REST OF MEA Artificial Intelligence in Drug Discovery Market by Deployment Type

    Cloud-based

    On-premise

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027